Compare Docusign Inc (DOCU) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Docusign Inc vs Moderna, Inc. — how do they compare? Docusign Inc trades at $58.39 (market cap $11.33B), while Moderna, Inc. trades at $60.75 (market cap $24.18B). The key difference: Moderna, Inc. is far larger — about 2.1× Docusign Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Docusign Inc nearer its low. Which is the better fit depends on your goals.
| DOCU | MRNA | |
|---|---|---|
Market Cap | $11.33B | $24.18B |
Sector | Technology | Health |
52-Week High | $85.01 | $81.80 |
52-Week Low | $41.75 | $22.36 |
Enterprise Value | $10.70B | $20.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
